CRISPR Therapeutics
CRISPR Therapeutics is a biotechnology company developing CRISPR-based gene-editing therapeutics across multiple disease areas. This Senior Manager position sits within the manufacturing/process development organization supporting advancement of next-generation gene-editing programs and cross-functional collaboration across R&D and CDMO partners. The role is U.S.-based with an expectation of in-person collaboration several days per week.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CRISPR Therapeutics.
CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story
2 days ago
Senior Scientist, Cell and Molecular Biology, Gene Editing
Editas Medicine
LNP Scientist
ElevateBio
Associate Director, Protein Engineering
Arbor
Sr Scientist – Director, Lipid Nanoparticle (LNP) Design and Delivery
Profluent
Senior Principal Engineer, Technology Transfer and Process Engineering, LNP
Eli Lilly and Company
Senior Scientist, LNP Sciences
Beam Therapeutics